scispace - formally typeset
A

Anna Karlsson

Researcher at Karolinska University Hospital

Publications -  170
Citations -  6291

Anna Karlsson is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Kinase & Thymidine kinase. The author has an hindex of 43, co-authored 168 publications receiving 5981 citations. Previous affiliations of Anna Karlsson include Pasteur Institute & Max Planck Society.

Papers
More filters
Journal ArticleDOI

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity.

Rosa Alvarez, +8 more
- 25 Nov 1994 - 
TL;DR: Several 4- or 5-monosubsituted and 4,5-disubstituted 1,2,3-triazole analogues of the anti-HIV-1 lead compound TSAO have been prepared and evaluated as inhibitors of HIV-1-induced cytopathicity.
Journal ArticleDOI

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases

An R. Van Rompay, +2 more
- 01 Aug 2000 - 
TL;DR: This overview is focused on the substrate specificity, tissue distribution, and subcellular location of the mammalian monophosphate kinases and their role in the activation of nucleoside and nucleotide analogs.
Journal ArticleDOI

Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus

Karin Tegmark, +2 more
- 01 Jul 2000 - 
TL;DR: It is shown that both the agr‐dependent suppression of protein A production and the sarA‐dependent stimulation of alpha‐toxin production is mediated via a new regulator, SarH1, which belongs to a family of Sar homologues.
Journal ArticleDOI

Decreased Amounts of Cell Wall-Associated Protein A and Fibronectin-Binding Proteins in Staphylococcus aureus sarA Mutants due to Up-Regulation of Extracellular Proteases

Anna Karlsson, +4 more
- 01 Aug 2001 - 
TL;DR: It can be concluded that the serine protease is the most important protease in the release of cell-bound FnBPs and protein A, which requires aureolysin to be activated.
Journal ArticleDOI

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase.

Jan Balzarini, +9 more
- 01 Jan 1993 - 
TL;DR: Serial passage of HIV-1 in CEM or MT-4 cell cultures in the presence of different HIV- 1-specific reverse transcriptase (RT) inhibitors yielded mutant viruses which were resistant (i.e., 200- to 1000-fold less sensitive) to the homologous compounds.